CMND
Clearmind Medicine Inc.
$2.10
-0.02 (-0.94%)
At close · Jul 8
Market Cap
$3.08M
Shares
1,485,551
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$2.10
Open$2.05
Day$2.00–2.16
52W$2.00–524.00
Avg vol 30d3.6M
Short int348K · 23.4% float · 1.0d
Short vol27%
DataNov 2022–Jul 2026
Equibles Rating
blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 15.8 · calm
Equity put/call 0.57
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−98%
below
Price vs 50-day avg
−45%
below
RSI (14)
32
neutral
MACD trend
Positive
52-week position
0%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−45%
trailing
6-month return
−91%
trailing
YTD return
−88%
this year
Relative strength
−99%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $4 › 200d $87 — 200d above 50d
Institutional flow
Accumulating
+67% holders QoQ · +3 funds added
Insider flow
Accumulating
Net +$211.8K over 90 days · 50% sells
Short interest
Rising
23.41% of float · ▲ +758.6% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
5 holders — 13F breadth
Squeeze score
59
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
162%
annualized · 1-yr
Max drawdown
−100%
past year
ATR
18.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
FQ3-26 quarter ends
~Jul 31, 2026
Est
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−98%
Bearish
Price vs 50-day avg
−45%
Bearish
RSI (14)
32
Neutral
MACD trend
Positive
Bullish
52-week position
0%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $4 › 200d $87 — 200d above 50d
Institutional flow
Accumulating
+67% holders QoQ · +3 funds added
Insider flow
Accumulating
Net +$211.8K over 90 days · 50% sells
Short interest
Rising
23.41% of float · ▲ +758.6% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
5 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $2
Now $2 · 0%
52-wk high $524
vs 200-day avg -98%
vs 50-day avg -45%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CMND
this stock
Clearmind Medicine Inc.
|
$3.08M | -88.4% | — | — | 23.4% |
|
ONC
BeOne Medicines Ltd.
|
$437.67B | -0.6% | +22179.2% | 890.7 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$126.01B | +9.9% | +46.2% | 29.5 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$70.03B | -14.0% | +20.8% | 16.3 | 3.2% |
|
ARGX
Argenx SE
|
$56.84B | +8.8% | — | — | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Accumulating
Holders
5
- % held
- 3.0%
- Net QoQ
- +38.3K sh
- Top holder
- XTX Topco Ltd
Held
Float
Short & Settlement
Smart Money
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CMND | -4.6% | -44.6% | -91.4% | -4.6% | -88.4% |
| SPY | -0.2% | +0.8% | +7.4% | -0.2% | +9.3% |
| vs SPY | -4.4% | -45.4% | -98.8% | -4.4% | -97.7% |